Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rodgers

Showing results (41-50 of 306) with videos related to

Pageof 31
Sort By:
Endocrine Reviews|September 14, 2021
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating DrugsBuel D Rodgers, Christopher W Ward
Progress in Medicinal Chemistry|January 9, 2003
Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1Jeffrey W Corbett, James D Rodgers
The Journal of Endocrinology|August 9, 2012
Myostatin inhibits myosatellite cell proliferation and consequently activates differentiation: evidence for endocrine-regulated transcript processingDilip K Garikipati, Buel D Rodgers
The Medical Journal of Australia|June 9, 1986
Box jellyfish antivenom and "Irukandji" stingsP Fenner, D Rodgers, J Williamson
Bulletin of Environmental Contamination and Toxicology|February 1, 1977
Effects of carbaryl on body weight and fat reserves of dietetically-stressed bobwhitesR D Rodgers, R J Robel
Journal of Quality in Clinical Practice|June 1, 1995
Diabetic control and hypoglycaemia in the Illawarra area of NSW, Australia: a comparison with the DCCTR Moses, D Rodgers, R Griffiths
Environmental Science & Technology|May 12, 2001
Electrochemical treatment of 2,4,6-trinitrotoluene and related compoundsJ D Rodgers, N J Bunce
Endocrine Reviews|July 2, 2008
Clinical, agricultural, and evolutionary biology of myostatin: a comparative reviewBuel D Rodgers, Dilip K Garikipati
Expert Opinion on Emerging Drugs|May 22, 2018
Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphomaThomas D Rodgers, Patrick M Reagan
Current Treatment Options in Oncology|May 30, 2018
Pitfalls of Combining Novel Agents in LymphomaThomas D Rodgers, Paul M Barr
Pageof 31

Showing results (41-50 of 306) with videos related to

Sort By:
Pageof 31
Endocrine Reviews|September 14, 2021
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating DrugsBuel D Rodgers, Christopher W Ward
Progress in Medicinal Chemistry|January 9, 2003
Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1Jeffrey W Corbett, James D Rodgers
The Journal of Endocrinology|August 9, 2012
Myostatin inhibits myosatellite cell proliferation and consequently activates differentiation: evidence for endocrine-regulated transcript processingDilip K Garikipati, Buel D Rodgers
The Medical Journal of Australia|June 9, 1986
Box jellyfish antivenom and "Irukandji" stingsP Fenner, D Rodgers, J Williamson
Bulletin of Environmental Contamination and Toxicology|February 1, 1977
Effects of carbaryl on body weight and fat reserves of dietetically-stressed bobwhitesR D Rodgers, R J Robel
Journal of Quality in Clinical Practice|June 1, 1995
Diabetic control and hypoglycaemia in the Illawarra area of NSW, Australia: a comparison with the DCCTR Moses, D Rodgers, R Griffiths
Environmental Science & Technology|May 12, 2001
Electrochemical treatment of 2,4,6-trinitrotoluene and related compoundsJ D Rodgers, N J Bunce
Endocrine Reviews|July 2, 2008
Clinical, agricultural, and evolutionary biology of myostatin: a comparative reviewBuel D Rodgers, Dilip K Garikipati
Expert Opinion on Emerging Drugs|May 22, 2018
Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphomaThomas D Rodgers, Patrick M Reagan
Current Treatment Options in Oncology|May 30, 2018
Pitfalls of Combining Novel Agents in LymphomaThomas D Rodgers, Paul M Barr
Pageof 31